Estrella Immunopharma, Inc. (ESLAW) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $13.54M | +351.9% |
| 2024 | $3.00M | -69.3% |
| 2023 | $9.77M | +268.3% |
| 2022 | $2.65M | +63.4% |
| 2021 | $1.62M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $13.54M | +351.9% |
| 2024 | $3.00M | -69.3% |
| 2023 | $9.77M | +268.3% |
| 2022 | $2.65M | +63.4% |
| 2021 | $1.62M | — |